CoChat
Cited by 27

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Structural Characterization of the Amyloid Precursor Protein Transmembrane Domain and Its γ-Cleavage Site

Itkin, Anna, Salnikov, Evgeniy S., Aisenbrey, Christopher, Raya, Jesus, Glattard, Elise, Raussens, Vincent, Ruysschaert, Jean-Marie, Bechinger, Burkhard · 2017 · ACS Omega

Abstract

Alzheimer’s disease is the most common form of dementia that affects about 50 million of sufferers worldwide. A major role for the initiation and progression of Alzheimer’s disease has been associated with the amyloid β-peptide (Aβ), which is a protease cleavage product of the amyloid precursor protein. The amyloid precursor protein is an integral membrane protein with a single transmembrane domain. Here, we assessed the structural integrity of the transmembrane domain within oriented phosphatidylcholine lipid bilayers and determined the tilt angle distribution and dynamics of various subdomains using solid-state NMR and attenuated total reflectance Fourier transform infrared spectroscopies. Although the overall secondary structure of the transmembrane domain is α-helical, pronounced conformational and topological heterogeneities were observed for the γ- and, to a lesser extent, the ζ-cleavage site, with pronounced implications for the production of Aβ and related peptides, the development of the disease, and pharmaceutical innovation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsomega.7b00619

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 57

  1. Korsak, 2015, Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer’s Disease, Adv. Exp. Med. Biol., 870, 401, 10.1007/978-3-319-20164-1_14 · DOI
  2. Musiek, 2015, Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’, Nat. Neurosci., 18, 800, 10.1038/nn.4018 · DOI · Paper page
  3. Nguyen, 2015, The human beta-amyloid precursor protein: biomolecular and epigenetic aspects, Biomol. Concepts, 6, 11, 10.1515/bmc-2014-0041 · DOI
  4. Agostinho, 2015, Localization and Trafficking of Amyloid-beta Protein Precursor and Secretases: Impact on Alzheimer’s Disease, J. Alzheimer’s Dis., 45, 329, 10.3233/JAD-142730 · DOI
  5. Nhan, 2015, The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes, Acta Neuropathol., 129, 1, 10.1007/s00401-014-1347-2 · DOI · Paper page
  6. Nicolas, 2014, Amyloid precursor protein and neural development, Development, 141, 2543, 10.1242/dev.108712 · DOI · Paper page
  7. van der Kant, 2015, Cellular functions of the amyloid precursor protein from development to dementia, Dev. Cell, 32, 502, 10.1016/j.devcel.2015.01.022 · DOI · Paper page
  8. Nagase, 2014, The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer’s Disease, Curr. Drug Discovery Technol., 11, 243, 10.2174/1570163811666141121101358 · doi:10.2174/1570163811666141121101358
  9. Kotler, 2014, Differences between amyloid-beta aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer’s disease, Chem. Soc. Rev., 43, 6692, 10.1039/C3CS60431D · DOI · Paper page
  10. Korshavn, 2017, Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-beta, J. Biol. Chem., 292, 4638, 10.1074/jbc.M116.764092 · DOI · Paper page
  11. Vassar, 1999, Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE, Science, 286, 735, 10.1126/science.286.5440.735 · DOI · Paper page
  12. Zhao, 2004, Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein, J. Biol. Chem., 279, 50647, 10.1074/jbc.C400473200 · DOI
  13. Krishnaswamy, 2009, The structure and function of Alzheimer's gamma secretase enzyme complex, Crit. Rev. Clin. Lab. Sci., 46, 282, 10.3109/10408360903335821 · DOI
  14. Scheuermann, 2001, Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer’s disease, J. Biol. Chem., 276, 33923, 10.1074/jbc.M105410200 · DOI · Paper page
  15. Miyashita, 2009, Transmembrane structures of amyloid precursor protein dimer predicted by replica-exchange molecular dynamics simulations, J. Am. Chem. Soc., 131, 3438, 10.1021/ja809227c · DOI
  16. Richter, 2010, Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization, Proc. Natl. Acad. Sci. U.S.A., 107, 14597, 10.1073/pnas.1003026107 · DOI · Paper page
  17. Barrett, 2012, The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol, Science, 336, 1168, 10.1126/science.1219988 · DOI · Paper page
  18. Nadezhdin, 2012, Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environment, FEBS Lett., 586, 1687, 10.1016/j.febslet.2012.04.062 · DOI
  19. Dominguez, 2014, Transmembrane fragment structures of amyloid precursor protein depend on membrane surface curvature, J. Am. Chem. Soc., 136, 854, 10.1021/ja410958j · DOI
  20. Lu, 2011, Evidence from solid-state NMR for nonhelical conformations in the transmembrane domain of the amyloid precursor protein, Biophys. J., 100, 711, 10.1016/j.bpj.2010.12.3696 · DOI
  21. Sato, 2009, A helix-to-coil transition at the epsilon-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis, Proc. Natl. Acad. Sci. U.S.A., 106, 1421, 10.1073/pnas.0812261106 · DOI
  22. Dominguez, 2016, Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein, Proc. Natl. Acad. Sci. U.S.A., 113, E5281, 10.1073/pnas.1606482113 · DOI
  23. Russ, 2000, The GxxxG motif: A framework for transmembrane helix-helix association, J. Mol. Biol., 296, 911, 10.1006/jmbi.1999.3489 · DOI · Paper page
  24. Munter, 2007, GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42, EMBO J., 26, 1702, 10.1038/sj.emboj.7601616 · DOI · Paper page
  25. Kienlen-Campard, 2008, Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs, J. Biol. Chem., 283, 7733, 10.1074/jbc.M707142200 · DOI
  26. Sagi, 2011, Substrate sequence influences gamma-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein, J. Biol. Chem., 286, 39794, 10.1074/jbc.M111.277228 · DOI
  27. Mori, 2016, Molecular dynamics simulations of biological membranes and membrane proteins using enhanced conformational sampling algorithms, Biochim. Biophys. Acta, 1858, 1635, 10.1016/j.bbamem.2015.12.032 · DOI
  28. Antzutkin, 2003, Site-specific identification of non-beta-strand conformations in Alzheimer’s beta-amyloid fibrils by solid-state NMR, Biophys. J., 84, 3326, 10.1016/S0006-3495(03)70057-5 · DOI
  29. Goormaghtigh, 1990, Polarized Attenuated Total Reflection Infrared Spectroscopy as a Tool to Investigate the Conformation and Orientation of Membrane Components, 285
  30. Bechinger, 1999, Membrane Helix Orientation from Linear Dichroism of Infrared Attenuated Total Reflection Spectra, Biophys. J., 76, 552, 10.1016/S0006-3495(99)77223-1 · DOI
  31. Bechinger, 2003, Alignment and structural analysis of membrane polypeptides by 15N and 31P solid-state NMR spectroscopy, Concepts Magn. Reson., 18A, 130, 10.1002/cmr.a.10070 · DOI
  32. Bechinger, 2011, The structural and topological analysis of membrane-associated polypeptides by oriented solid-state NMR spectroscopy: Established concepts and novel developments, Biophys. Chem., 153, 115, 10.1016/j.bpc.2010.11.002 · DOI
  33. Aisenbrey, 2004, Tilt and rotational pitch angles of membrane-inserted polypeptides from combined 15N and 2H solid-state NMR spectroscopy, Biochemistry, 43, 10502, 10.1021/bi049409h · DOI
  34. Verly, 2009, Structure and membrane interactions of the antibiotic peptide dermadistinctin k by solution and oriented 15 N and 31 P solid-state NMR spectroscopy, Biophys. J., 96, 2194, 10.1016/j.bpj.2008.11.063 · DOI
  35. Kim, 2009, Evidence of pores and thinned lipid bilayers induced in oriented lipid membranes interacting with the antimicrobial peptides, magainin-2 and aurein-3.3, Biochim. Biophys. Acta, 1788, 1482, 10.1016/j.bbamem.2009.04.017 · DOI
  36. Holt, 2010, Order Parameters of a Transmembrane Helix in a Fluid Bilayer: Case Study of a WALP Peptide, Biophys. J., 98, 1864, 10.1016/j.bpj.2010.01.016 · DOI
  37. Michalek, 2013, Structure and topology of the huntingtin 1–17 membrane anchor by a combined solution and solid-state NMR approach, Biophys. J., 105, 699, 10.1016/j.bpj.2013.06.030 · DOI · Paper page
  38. Osenkowski, 2008, Direct and potent regulation of gamma-secretase by its lipid microenvironment, J. Biol. Chem., 283, 22529, 10.1074/jbc.M801925200 · DOI · Paper page
  39. Hartmann, 2007, Alzheimer’s disease: the lipid connection, J. Neurochem., 103, 159, 10.1111/j.1471-4159.2007.04715.x · DOI · Paper page
  40. Resende, 2009, Membrane structure and conformational changes of the antibiotic heterodimeric peptide distinctin by solid-state NMR spectroscopy, Proc. Natl. Acad. Sci. U.S.A., 106, 16639, 10.1073/pnas.0905069106 · DOI
  41. Gorman, 2008, Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer’s disease mutants, BMC Neurosci., 9, 17, 10.1186/1471-2202-9-17 · DOI
  42. Eggert, 2009, Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production, J. Biol. Chem., 284, 28943, 10.1074/jbc.M109.038646 · DOI · Paper page
  43. Ramamoorthy, 2004, PISEMA Solid-State NMR Spectroscopy, Annu. Rep. NMR Spectrosc., 52, 1, 10.1016/S0066-4103(04)52001-X · DOI · Paper page
  44. Bai, 2015, An atomic structure of human gamma-secretase, Nature, 525, 212, 10.1038/nature14892 · DOI · Paper page
  45. Chan, 2000, Fmoc Solid-Phase Peptide Synthesis: A Practical Approach
  46. Andrushchenko, 2007, Optimization of the hydrochloric acid concentration used for trifluoroacetate removal from synthetic peptides, J. Pept. Sci., 13, 37, 10.1002/psc.793 · DOI
  47. Goormaghtigh, 1994, Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. I. Assignments and model compounds, Sub-Cell. Biochem., 23, 329, 10.1007/978-1-4615-1863-1_8 · DOI · Paper page
  48. Fringeli, 1981, Infrared membrane spectroscopy, Mol. Biol. Biochem. Biophys., 31, 270, 10.1007/978-3-642-81537-9_6 · DOI · Paper page
  49. Aisenbrey, 2010, Solid-State NMR Investigations of Membrane-Associated Antimicrobial Peptides, 209, 10.1007/978-1-60761-594-1_14 · DOI
  50. Rance, 1983, Obtaining High-Fidelity Spin-1/2 Powder Spectra in Anisotropic Media: Phase-Cycled Hahn Echo Spectroscopy, J. Magn. Reson., 52, 221, 10.1016/0022-2364(83)90190-7 · DOI
  51. Bechinger, 1991, Flat-Coil Probe for NMR Spectroscopy of Oriented Membrane Samples, J. Magn. Reson., 95, 585, 10.1016/0022-2364(91)90173-Q · doi:10.1016/0022-2364(91)90173-q
  52. Hediger, 1995, Adiabatic passage Hartmann-Hahn cross polarization in NMR under magic angle sample spinning, Chem. Phys. Lett., 240, 449, 10.1016/0009-2614(95)00505-X · DOI · Paper page
  53. Bertani, 2014, 15N chemical shift referencing in solid state NMR, Solid State Nucl. Magn. Reson., 61–62, 15, 10.1016/j.ssnmr.2014.03.003 · DOI
  54. Davis, 1976, Quadrupolar Echo Deuteron Magnetic Resonance Spectroscopy in Ordered Hydrocarbon Chains, Chem. Phys. Lett., 42, 390, 10.1016/0009-2614(76)80392-2 · DOI · Paper page
  55. Salnikov, 2009, Analysis of the amide (15)N chemical shift tensor of the C(alpha) tetrasubstituted constituent of membrane-active peptaibols, the alpha-aminoisobutyric acid residue, compared to those of di- and tri-substituted proteinogenic amino acid residues, J. Biomol. NMR, 45, 373, 10.1007/s10858-009-9380-5 · DOI
  56. Batchelder, 1983, Methyl reorientation in polycrystalline amino acids and peptides: A 2H NMR spin lattice relaxation study, J. Am. Chem. Soc., 105, 2228, 10.1021/ja00346a021 · doi:10.1021/ja00346a021
  57. Mendonca de Moraes, 2004, Peptide-related alterations of membrane-associated water: Deuterium solid-state NMR investigations of phosphatidylcholine membranes at different hydration levels, Magn. Reson. Chem., 42, 155, 10.1002/mrc.1321 · doi:10.1002/mrc.1321

Metadata

Authors
Itkin, A., Salnikov, E. S., Aisenbrey, C., Raya, J., Glattard, E., Raussens, V., Ruysschaert, J.-M., & Bechinger, B.
Venue
ACS Omega
Published
2017-10-09
Volume
2
Issue
10
Pages
6525-6534
ISSN
2470-1343
Cited by
27
References
5
Language
en
Funders
  • Centre International de Recherche aux Frontières de la Chimie (NA)
  • FP7 People: Marie-Curie Actions (33439)
  • Agence Nationale de la Recherche (NA)
  • Fonds De La Recherche Scientifique - FNRS (70214.12)
  • Université de Strasbourg (NA)
  • Centre National de la Recherche Scientifique (NA)
  • Région Alsace (NA)
  • SAO-FRA (S#14025)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.